Basilea News Basilea News en Mon, 22 Dec 2014 10:05:56 +0100 Mon, 22 Dec 2014 10:05:56 +0100 Chameleon CMS (Webmaster Webmaster) (Webmaster Webmaster) <![CDATA[Swissmedic approves Basilea's antibiotic Zevtera® (ceftobiprole medocaril) for the treatment of pneumonia]]> Mon, 22 Dec 2014 07:15:00 +0100 <![CDATA[Basilea announces launch of antibiotic Zevtera® (ceftobiprole medocaril) in Germany]]>
  • First commercial launch
  • ]]>
    Fri, 05 Dec 2014 07:15:00 +0100
    <![CDATA[Basilea reports that U.S. FDA sets date of Advisory Committee meeting on isavuconazole NDA for the treatment of invasive aspergillosis and mucormycosis]]> Fri, 21 Nov 2014 11:49:47 +0100 <![CDATA[Basilea's oncology drug candidate BAL101553 induces significant anti-tumor effect in treatment-refractory tumor models]]>
  • BAL101553 anti-cancer activity in treatment-refractory cancer models, alone and in combination with radiotherapy, presented at EORTC-NCI-AACR Symposium*
  • BAL101553 has anti-tumor activity when administered i.v. or orally in
    in-vivo models of human cancer refractory to taxanes and epothilones
  • Combination of BAL101553 with radiotherapy led to profound tumor growth delay
  • ]]>
    Wed, 19 Nov 2014 07:15:00 +0100
    <![CDATA[Basilea reports granting of U.S. orphan drug designation to isavuconazole for the treatment of invasive candidiasis]]> Mon, 03 Nov 2014 07:15:00 +0100 <![CDATA[Basilea reports protocol amendment resulting in earlier completion of isavuconazole phase 3 invasive candidiasis study]]> Thu, 16 Oct 2014 07:15:00 +0200 <![CDATA[Basilea reports that further subgroup and health economic analyses of isavuconazole phase 3 studies will be presented at IDWeek conference]]> Wed, 08 Oct 2014 19:41:35 +0200 <![CDATA[Basilea's partner Astellas receives notification from U.S. FDA of acceptance of filing of isavuconazole NDA for the treatment of invasive aspergillosis and invasive mucormycosis]]> Sat, 06 Sep 2014 14:15:00 +0200 <![CDATA[Extensive data presented on Basilea's anti-infectives isavuconazole, ceftobiprole and BAL30072 at ICAAC ]]> Fri, 05 Sep 2014 07:15:00 +0200 <![CDATA[European Medicines Agency accepts Basilea's isavuconazole Marketing Authorization Application for review]]> Thu, 21 Aug 2014 07:15:00 +0200